Drug intelligence / Profile preview

toxaphene

Development stage
Discontinued
Lead developer
Hercules
Modality
Small Molecules
Administration
Topical
01

Overview

Toxaphene is a complex synthetic mixture of over 670 chlorinated camphenes and related bicyclic terpenes that was historically utilized as an organochlorine pesticide and veterinary acaricide. Developed in the 1940s, it became one of the most heavily used insecticides in the United States, primarily applied to cotton crops and used to control ectoparasites such as mange, lice, and ticks on livestock. Toxaphene acts as a noncompetitive antagonist at the GABA-A receptor-associated chloride channel, leading to central nervous system hyperexcitability, tremors, and convulsions. Due to its high persistence in the environment, bioaccumulation in aquatic and terrestrial food chains, and potential carcinogenicity, toxaphene was banned in the United States in 1990 and globally restricted under the 2001 Stockholm Convention on Persistent Organic Pollutants.

Brand names
Agricide Maggot KillerAgro-Chem Brand Torbidan 28AllotoxAlltexAlltoxAnatoxAttacAttac 6Attac6Attac-6Attac 8Attac8Attac-8Chem-PheneCotton Tox MP82CrestoxoCristoxo 90Cristoxo90Cristoxo-90Dr Roger's ToxeneEstonoxFasco-TerpeneGenipheneGy-pheneMelipaxMotoxPenphenePhenacidePhenatoxRigo Toxaphene 8Royal Brand Bean Tox 82Security Motox 63 cotton spraySecurity Tox-MP cotton spraySecurity Tox-Sol-6Strobane T-90Strobane-TToxadustToxakilToxon 63Toxon63Toxon-63
Other names
CamphechlorCamphochlorCamphoclorChlorinated campheneChlorocampheneKamfochlorOctachlorocamphenePolychlorocampheneToxaphentoxapheneToxyphen
02

Targets

ESRRA (Estrogen-related receptor alpha)ESR2 (ERβ)GABAA (Gamma-aminobutyric acid receptor)ESR1 (ERα)

Beyond the preview

Go deeper on toxaphene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on toxaphene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call